Market Overview:
The global tacrolimus injection market is expected to register a CAGR of xx% during the forecast period 2018-2030. The market growth can be attributed to the increasing prevalence of organ transplantations, rising awareness about organ donation and technological advancements in the field of organ transplantation. Based on type, the global tacrolimus injection market is segmented into 5 mg/mL and others. The 5 mg/mL segment is expected to account for a major share of the global tacrolimus injection market during the forecast period. This can be attributed to its high demand in adult and pediatric patients for prophylaxis or treatment of graft rejection after kidney, liver or heart transplants. Based on application, the global tacrolimus injection market is segmented into adult and children. The adult segment accounted for a major share of the global tacrolimus injection market in 2017 and is projected to grow at a significant rate duringthe forecast period owingto an increase in numberoforgan transplants across different regions worldwide.
Product Definition:
A tacrolimus injection is a medication that is used to help prevent organ rejection after a transplant. It works by suppressing the immune system.
5 mg/mL:
5 mg/mL is the concentration of tacrolimus in injectable form. It's a standard concentration for all commercial generic products and has been used as a reference point for potency analysis by various organizations since the early 90s. 5 mg/mL is also recognized as an international standard, which can be found in many European pharmacopeias (EP) and USP generics guidelines.
Others:
Others are the other ingredients used in Tacrolimus Injection. They consist of preservatives, flavors and colors, stabilizers among others. Some Others include excipients which are not essential for the action or function of the drug but help in improving its quality and consistency as well as enhance its appearance and texture among others.
Application Insights:
The global demand for tacrolimus in the pediatric population is expected to witness a CAGR of XX% from 2018 to 2030 owing to rising applications in various diseases such as rheumatoid arthritis, systemic lupus erythematosus, and juvenile idiopathic arthritis. In addition, factors such as increasing awareness about the availability of treatment options along with favorable reimbursement policies are anticipated to propel growth during the forecast period.
Adult patients accounted for a significant share in 2015 due to growing applications for immunosuppressive drugs after organ transplantation and chemotherapy-induced lymphoproliferative disorders.
Regional Analysis:
North America dominated the global tacrolimus injection market in 2017. The presence of a large number of Tacrolimus-based pharmaceutical companies and increased R&D investment by these companies are some factors attributing to its largest share. In addition, growing incidence of CVDs is also expected to drive the demand for immunosuppressants in this region over the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the coming years owing to increasing healthcare expenditure, rising awareness about organ transplantation and availability of novel therapies such as tacrolimus injections for organ rejection cases along with supportive government initiatives & programs are expected to boost regional market growth during the forecast period. Moreover, increasing prevalence rate of diabetes and other autoimmune diseases has led Asia Pacific countries like India & China etc.
Growth Factors:
- Increasing incidence of organ transplant surgeries due to rising prevalence of organ failures and chronic diseases
- Growing demand for better quality and longer lasting organs for transplantation procedures
- Technological advancements in organ preservation and transportation that are increasing the number of successful transplants
- Rising awareness about the benefits of tacrolimus therapy among patients with autoimmune diseases
- Increasing affordability of tacrolimus therapy due to genericization
Scope Of The Report
Report Attributes
Report Details
Report Title
Tacrolimus Injection Market Research Report
By Type
5 mg/mL, Others
By Application
Adult, Children
By Companies
Astellas Pharma, Pfizer, Jina Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
204
Number of Tables & Figures
143
Customization Available
Yes, the report can be customized as per your need.
Global Tacrolimus Injection Market Report Segments:
The global Tacrolimus Injection market is segmented on the basis of:
Types
5 mg/mL, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Adult, Children
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Astellas Pharma
- Pfizer
- Jina Pharma
Highlights of The Tacrolimus Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 5 mg/mL
- Others
- By Application:
- Adult
- Children
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tacrolimus Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Tacrolimus injection is a medication used to reduce inflammation. It is given by injection into a muscle or vein.
Some of the key players operating in the tacrolimus injection market are Astellas Pharma, Pfizer, Jina Pharma.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Tacrolimus Injection Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Tacrolimus Injection Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Tacrolimus Injection Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Tacrolimus Injection Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Tacrolimus Injection Market Size & Forecast, 2018-2028
4.5.1 Tacrolimus Injection Market Size and Y-o-Y Growth
4.5.2 Tacrolimus Injection Market Absolute $ Opportunity
Chapter 5 Global Tacrolimus Injection Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Tacrolimus Injection Market Size Forecast by Type
5.2.1 5 mg/mL
5.2.2 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Tacrolimus Injection Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Tacrolimus Injection Market Size Forecast by Applications
6.2.1 Adult
6.2.2 Children
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Tacrolimus Injection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Tacrolimus Injection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Tacrolimus Injection Analysis and Forecast
9.1 Introduction
9.2 North America Tacrolimus Injection Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Tacrolimus Injection Market Size Forecast by Type
9.6.1 5 mg/mL
9.6.2 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Tacrolimus Injection Market Size Forecast by Applications
9.10.1 Adult
9.10.2 Children
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Tacrolimus Injection Analysis and Forecast
10.1 Introduction
10.2 Europe Tacrolimus Injection Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Tacrolimus Injection Market Size Forecast by Type
10.6.1 5 mg/mL
10.6.2 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Tacrolimus Injection Market Size Forecast by Applications
10.10.1 Adult
10.10.2 Children
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Tacrolimus Injection Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Tacrolimus Injection Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Tacrolimus Injection Market Size Forecast by Type
11.6.1 5 mg/mL
11.6.2 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Tacrolimus Injection Market Size Forecast by Applications
11.10.1 Adult
11.10.2 Children
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Tacrolimus Injection Analysis and Forecast
12.1 Introduction
12.2 Latin America Tacrolimus Injection Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Tacrolimus Injection Market Size Forecast by Type
12.6.1 5 mg/mL
12.6.2 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Tacrolimus Injection Market Size Forecast by Applications
12.10.1 Adult
12.10.2 Children
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Tacrolimus Injection Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Tacrolimus Injection Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Tacrolimus Injection Market Size Forecast by Type
13.6.1 5 mg/mL
13.6.2 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Tacrolimus Injection Market Size Forecast by Applications
13.10.1 Adult
13.10.2 Children
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Tacrolimus Injection Market: Competitive Dashboard
14.2 Global Tacrolimus Injection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Astellas Pharma
14.3.2 Pfizer
14.3.3 Jina Pharma
